SPRB

Spruce Biosciences
SPRB

Overview Fund Trends Analyst Outlook Journalist POV
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$207
93% upside
High target

2 analyst ratings

positive
1  neutral
50%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Citizens
Citizens
Jonathan Wolleben
0% 1-yr SPRB win rate
28 Oct ‘25 2 days ago
Leerink Partners
Leerink Partners
Joseph Schwartz
21 Oct ‘25 9 days ago